N-(1-Methyl-2-pyrrolidinylmethyl)-2,3-dimethoxy-5-methylsulfamoyl benzamide and its derivatives
AssigneeSociete d'Etudes Scientifiques et Industrielles de l'Ile-de-France
InventorsMichel Thominet, Jacques Perrot
Life of this patent
Estimating the term…
Abstract
The present invention relates to a novel veratramide, N-(1-methyl-2-pyrroinyl-methyl)-2,3-dimethoxy-5-methylsulphamoyl benzamide, its pharmacologically acceptable acid addition salts, its quaternary ammonium salts, its oxides and its levorotatory and dextrorotatory isomers and their use in the treatment of disorders of the lower urinary apparatus.
Claims1
A compound selected from the group consisting of N-(1-methyl-2-pyrrolidinylmethyl)-2,3-dimethoxy-5-methylsulphamoyl benzamide, its N-oxide, its pharmacologically acceptable acid addition salts, its quaternary ammonium salts and levorotatory and dextrorotatory isomers thereof.
Dependencies are inferred from the claim text.